Abstract
Molecular pathology findings that are related to lymphomagenesis may be used as diagnostic tools, in conjunction with conventional methods. In particular, the use of genetic lesions as diagnostic markers of non-Hodgkin's lymphomas is supported by the selective association of certain genetic alterations with specific histological entities.
Publication types
-
English Abstract
-
Research Support, Non-U.S. Gov't
-
Review
MeSH terms
-
Biomarkers, Tumor / analysis
-
Cell Transformation, Neoplastic
-
Humans
-
Immunophenotyping
-
Leukemia, B-Cell / etiology
-
Leukemia, B-Cell / genetics
-
Leukemia, B-Cell / pathology
-
Lymphoma, Non-Hodgkin / classification
-
Lymphoma, Non-Hodgkin / etiology*
-
Lymphoma, Non-Hodgkin / genetics
-
Lymphoma, Non-Hodgkin / pathology
-
Neoplasm Proteins / analysis
-
Neoplastic Stem Cells / pathology
Substances
-
Biomarkers, Tumor
-
Neoplasm Proteins